Enhance patient care through personalized risk assessment

According to the recent 2021 European Society of Cardiology (ESC) Guidelines on cardiovascular disease prevention in clinical practice, the importance of atherosclerosis cardiovascular (CV) disease prevention remains undisputed and should be delivered:

  • at the general population level by promoting healthy lifestyle behavior
  • at the individual level by tackling unhealthy lifestyles and by reducing levels of causal CV risk factors, such as low-density lipoprotein cholesterol (LDL-c), non-high density lipoprotein cholesterol (non-HDLc) and/or blood pressure.1

Unlock patient potential with our risk calculator

Personalized patient communication is crucial. Individualized cardiovascular risk assessment supports clinical decision-making and patient engagement, helping set personalized health goals.

This tool also illustrates the impact of poor lipid control-often due to non-adherence to medication or unhealthy lifestyle choices – empowering patients to make informed changes.2

This user-friendly calculator, based on the latest ESC guidelines, is suitable for all patients, including those at very high risk. It integrates Non-HDLc values into the Systemic Cornoary Risk Estimation 2 (SCORE23) and SCORE2-Older Persons (SCORE2-OP4) algorithms, offering healthcare professionals clear recommendations for LDL-c and non-HDLe targets consistent with ESC/EAS guidelines.


  1. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B; ESC National Cardiac Societies; ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34):3227-3337.
  2. Michie S, Wood CE, Johnston M, Abraham C, Francis JJ, Hardeman W. Behaviour change techniques: the development and evaluation of a taxonomic method for reporting and describing behaviour change interventions (a suite of five studies involving consensus methods, randomised controlled trials and analysis of qualitative data). Health Technol Assess. 2015 Nov;19(99):1-188.
  3. SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021 Jul 1;42(25):2439-2454.
  4. SCORE2-OP working group and ESC Cardiovascular risk collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021 Jul 1;42(25):2455-2467.